HER-2/neu gene amplification in stages I-IV breast cancer detected by fluorescent in situ hybridization
- 1 March 1999
- journal article
- research article
- Published by Elsevier in Genetics in Medicine
- Vol. 1 (3) , 98-103
- https://doi.org/10.1097/00125817-199903000-00007
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Fluorescence in situ hybridization assessment of chromosome 8 copy number in stage i and stage ii infiltrating ductal carcinoma of the breastCancer Genetics and Cytogenetics, 1997
- Stage I and Stage II Infiltrating Ductal Carcinoma of the Breast Analyzed for Chromosome 8 Copy Number Using Fluorescent in situ HybridizationPathobiology, 1997
- ERBB2 and chromosome 17 centromere studies of ovarian cancer by fluorescence in situ hybridizationGenes, Chromosomes and Cancer, 1996
- Fluorescentin situ hybridization assessment of chromosome 8 copy number in breast cancerBreast Cancer Research and Treatment, 1996
- c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast CancerNew England Journal of Medicine, 1994
- Prognostic factors in early breast carcinomaCancer, 1994
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization.Proceedings of the National Academy of Sciences, 1986